Valdés-Mora, F., Gould, C. M., Colino-Sanguino, Y., Qu, W., Song, J. Z., Taylor, K. M., . . . Clark, S. J. (2017). Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationValdés-Mora, Fátima, et al. Acetylated Histone Variant H2A.Z Is Involved in the Activation of Neo-enhancers in Prostate Cancer. Nature Portfolio, 2017.
MLA (8th ed.) CitationValdés-Mora, Fátima, et al. Acetylated Histone Variant H2A.Z Is Involved in the Activation of Neo-enhancers in Prostate Cancer. Nature Portfolio, 2017.
Warning: These citations may not always be 100% accurate.